歌礼制药-B(Ascletis-B)宣布,公司已成功入选港股通名单,该名单适用于上海-香港股票市场交易互联互通机制以及深圳-香港股票市场交易互联互通机制。这一里程碑式的进展,标志着公司股票正式进入沪深港通体系,为两地投资者提供了更为便捷的投资通道。
歌礼制药-B(Ascletis-B)宣布,公司已成功入选港股通名单,该名单适用于上海-香港股票市场交易互联互通机制以及深圳-香港股票市场交易互联互通机制。这一里程碑式的进展,标志着公司股票正式进入沪深港通体系,为两地投资者提供了更为便捷的投资通道。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.